Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Behavioral Pharmacology of THC and Alpha-pinene
NCT04130633Phase 1Completed
- Sponsor
- Johns Hopkins University
- Start
- Nov 2020
- Primary completion
- Mar 2024
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of alpha-pinene (6 arms), sponsored by Johns Hopkins University. Primary endpoints: Mean Peak Change From Baseline Drug Effect as Assessed by the Drug Effect Questionnaire (DEQ), Mean Peak Change From Baseline Psychomotor Performance as Assessed by the Digit Symbol Substitution Task (DSST) and 1 more. Started Nov 2020; status: completed.
02
Drugs
alpha-pinene
Beyond the preview
Go deeper on NCT04130633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04130633.